SCHEMBL22730487

SCHEMBL22730487

Cc1cc(C)cc(Oc2cccc(Br)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ MAOB P27338 5/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ MEN1 O00255 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ACHE P22303 1/20 0.42
▸ EGFR P00533 3/20 0.41
▸ HTT P42858 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GAA P10253 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ GFER P55789 1/20 0.41
▸ NLRP1 Q9C000 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ RAPGEF4 Q8WZA2 1/20 0.41
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16186449 0.85 ALDH1A1 (0.61) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL457828 0.85 MAOB (0.54) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL2628178 0.84 MAOB (0.59) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL29530517 0.83 MAOB (0.48) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL9486297 0.83 ALDH1A1 (0.70) ALDH1A1MAOBSMN1; SMN2MEN1MAPT
SCHEMBL3842164 0.83 MAOB (0.52) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL20566087 0.81 MAOB (0.47) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL24364239 0.81 MAOB (0.44) ALDH1A1MAOBMAPK1SMN1; SMN2MEN1
SCHEMBL3839157 0.81 ALDH1A1 (0.54) ALDH1A1MAOBSMN1; SMN2MEN1MAPT
SCHEMBL3838974 0.81 ALDH1A1 (0.54) ALDH1A1MAOBSMN1; SMN2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377474-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377474-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF BRDT, BRD4, BRD3 ALDH1A1 1617/4885MAOB 289/4885MAPK1 1199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback